Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion
Tycho Peterson

Tycho Peterson Analyst Performance

Managing Director at Jefferies Financial Group

Tycho Peterson is a stock analyst at Jefferies Financial Group focused in the medical sector, covering 19 publicly traded companies. Over the past year, Tycho Peterson has issued 17 stock ratings, including buy, hold, and sell recommendations. While full access to Tycho Peterson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tycho Peterson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
33 Last 10 Years
Buy Recommendations
69.70% 23 Buy Ratings
Companies Covered
19 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy69.7%23 ratings
Hold18.2%6 ratings
Sell12.1%4 ratings

Out of 33 total stock ratings issued by Tycho Peterson at Jefferies Financial Group, the majority (69.7%) have been Buy recommendations, followed by 18.2% Hold and 12.1% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
57.9% of companies on NASDAQ
11 companies
NYSE
42.1% of companies on NYSE
8 companies

Tycho Peterson, an analyst at Jefferies Financial Group, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
17 companies
89.5%
Services
2 companies
10.5%

Tycho Peterson of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on Services companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
5 companies
26.3%
MEDICAL SERVICES
5 companies
26.3%
MED PRODUCTS
2 companies
10.5%
SERVICES – HEALTH
2 companies
10.5%
MEDICAL INFO SYS
1 company
5.3%
MED - OUTP/HM CRE
1 company
5.3%
MED - BIOMED/GENE
1 company
5.3%
MED/DENTAL - SUPP
1 company
5.3%
ANALYTICAL INSTRUMENTS
1 company
5.3%

About Tycho Peterson

Tycho Peterson is a Managing Director and Senior Equity Analyst at Jefferies, specializing in healthcare, diagnostics, and life sciences tools. He covers companies such as Exact Sciences, Pacific Biosciences, Natera, and SomaLogic, maintaining a strong track record with a success rate near 70% and an average return of approximately 14.6% on rated stocks, ranking him among the more consistent analysts on Wall Street. Peterson joined Jefferies as Managing Director in April 2024 after serving as CFO at Adaptive Biotechnologies and holding strategy and advisory roles at Element Biosciences and SomaLogic, and he previously served as Managing Director at JPMorgan Securities. He holds an MBA from the University of Oxford, a bachelor's degree from Cornell University, and maintains relevant securities industry credentials and board memberships in prominent healthcare companies.
Follow on LinkedIn

Tycho Peterson's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
5/7/2026Downgrade$10.96$12.50Hold
Tempus AI, Inc. stock logo
TEM
Tempus AI
4/13/2026Initiated Coverage$42.94$35.00Underperform
Veracyte, Inc. stock logo
VCYT
Veracyte
4/13/2026Initiated Coverage$31.09$45.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
4/13/2026Initiated Coverage$18.07$28.00Buy
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
3/20/2026Upgrade$1,189.84$1,450.00Buy
Avantor, Inc. stock logo
AVTR
Avantor
2/12/2026Reiterated Rating$9.66$8.00Underperform
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2/10/2026Boost Price Target$204.41$220.00Buy
Revvity Inc. stock logo
RVTY
Revvity
2/2/2026Boost Price Target$105.25$105.00Hold
Danaher Corporation stock logo
DHR
Danaher
1/29/2026Boost Price Target$219.62$275.00Overweight
Danaher Corporation stock logo
DHR
Danaher
1/28/2026Boost Price Target$224.00$265.00Buy
Avantor, Inc. stock logo
AVTR
Avantor
12/17/2025Downgrade$11.19Underperform
Avantor, Inc. stock logo
AVTR
Avantor
12/17/2025Downgrade$11.19$9.00Underperform
Billiontoone, Inc. stock logo
BLLN
Billiontoone
12/1/2025Initiated Coverage$130.18$117.00Hold
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/24/2025Downgrade$100.90$105.00Hold
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
10/21/2025Boost Price Target$183.49$215.00Buy
Waters Corporation stock logo
WAT
Waters
8/4/2025Set Price Target$285.97$385.00Buy
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
5/29/2025Lower Price Target$115.33$155.00Overweight
GeneDx Holdings Corp. stock logo
WGS
GeneDx
5/9/2025Upgrade$56.44$80.00Buy
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
5/8/2025Upgrade$32.73$44.00Buy
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
5/5/2025Upgrade$1,103.95$1,110.00Hold
Danaher Corporation stock logo
DHR
Danaher
4/22/2025Lower Price Target$192.06$260.00Overweight
Danaher Corporation stock logo
DHR
Danaher
4/22/2025Lower Price Target$192.06$230.00Buy
Labcorp Holdings Inc. stock logo
LH
Labcorp
2/6/2025Boost Price Target$247.33$290.00Buy
Danaher Corporation stock logo
DHR
Danaher
1/29/2025Lower Price Target$223.12$260.00Buy